Azenta, Inc.

NASDAQ:AZTA

Medical - Instruments & Supplies

Healthcare
$48.69 -0.11%

-$0.03 today

Market cap
$2.13B
Beta
1.40
P/E (TTM)
-5.9
EPS (TTM)
-$3.87
52W Low $15.93High $41.73

Volume 0.69M

Average 1.16M

AZTA Net Margin

Net income as a percentage of revenue, showing how much of each sales dollar becomes profit.

Azenta, Inc.NASDAQ: AZTA

Net Margin · Q4 FY2026 · quarter ended Sep 2026

Net margin narrows to 4.1%

Net margin was 4.1% in Q4 FY2026, down 27.9 pp from a year earlier. On a trailing-twelve-month basis it was -26.9%, down 17.9 pp year over year. Over 3 fiscal years it narrowed by 24.7 pp.

Context

  • Net margin widened in 1 of the last 3 fiscal years.

What to watch

Whether net margin reaches the consensus estimate from 4 analysts of 3.9% for the fiscal year ending Sep 2027, up from -26.9% in FY2026.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
4.1%+2.5 pp QoQ
Last fiscal yearSep 2026
-26.9%-17.5 pp YoY
LTMSep 2026
-26.9%-17.9 pp YoY
Net Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-27.9 pp+15.2 pp+43.1 pp
1 year-17.5 pp+30.8 pp+48.3 pp
3 years-24.7 pp+32.9 pp+57.6 pp
5 years——
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

Net Margin history

Percent of revenue · from the income statement

Latest · FY2026
-26.9%
Year-over-year change
-17.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

Net Margin vs competitors

How AZTA compares with its peers on the latest reported figures

  • AZTA's LTM Sep 2026 net margin of -26.9% is the lowest of the 10 companies compared; the peer median is 8.6%.
  • Its year-over-year change of -17.9 pp is the lowest of 10, against a peer median of +3.5 pp.
  • Over three fiscal years its change of -24.7 pp compares with a peer median of +1.9 pp.
AZTA Competitors Peer median
Net Margin for AZTA and competitors
Company Period LTM level YoY 3-year change
SOLVSolventum CorporationLTM Jun 202617.3% +12.7 pp+2.2 pp
DHRDanaher CorporationLTM Sep 202616.9% +2.5 pp-12.3 pp
TMOThermo Fisher Scientific Inc.LTM Sep 202615.0% -0.1 pp-0.4 pp
TECHBio-Techne CorporationLTM Sep 202614.0% +7.6 pp-10.1 pp
BIOBio-Rad Laboratories, Inc.LTM Jun 20268.6% -3.9 pp+158.9 pp
MLABMesa Laboratories, Inc.LTM Mar 20262.7% +3.5 pp+2.3 pp
BRKRBruker CorporationLTM Jun 2026-2.0% -4.3 pp-12.0 pp
NEOGNeogen CorporationLTM Aug 2026-6.3% +111.3 pp+1.9 pp
BLFSBioLife Solutions, Inc.LTM Mar 2026-10.5% +4.2 pp+170.8 pp
AZTAAzenta, Inc.LTM Sep 2026-26.9% -17.9 pp-24.7 pp
Peer median (excluding AZTA) 8.6%+3.5 pp+1.9 pp

Competitors are the stored peer set for AZTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2022
Sep 2022
FY2023
Sep 2023
FY2024
Sep 2024
FY2025
Sep 2025
FY2026
Sep 2026
Revenue555.5M665.07M573.45M593.82M621.7M
Cost of Revenue324.88M431.82M318.83M323.54M346.74M
Gross Profit230.62M233.26M254.62M270.28M274.96M
Gross Margin41.5%35.1%44.4%45.5%44.2%
Research & Development27.54M33.96M31.52M30.39M37.92M
Selling, General & Admin227.1M281.5M253.08M251.16M257.53M
Operating Expenses254.64M315.45M284.6M281.55M449.66M
Depreciation & Amortization53.7M85.58M90.74M61.21M0
EBITDA48.36M55.15M71.62M54.07M(151.01M)
EBITDA Margin8.7%8.3%12.5%9.1%-24.3%
Operating Income(24.02M)(82.2M)(29.98M)(11.27M)(174.7M)
Operating Margin-4.3%-12.4%-5.2%-1.9%-28.1%
Interest Income20.29M43.74M33.18M18.78M17.83M
Interest Expense4.59M0000
Other Income / Expenses14.09M51.77M10.86M4.13M23.69M
Income Before Tax(9.94M)(30.43M)(19.13M)(7.14M)(151.01M)
Pre-Tax Margin-1.8%-4.6%-3.3%-1.2%-24.3%
Income Tax Expense1.35M(17.55M)5.24M(31.6M)6.86M
Net Income(428.96M)(14.26M)(164.9M)(55.76M)(166.99M)
Net Margin-77.2%-2.1%-28.8%-9.4%-26.9%
EPS (Basic)(0.15)(0.22)(3.09)(1.22)(3.70)
EPS (Diluted)(0.15)(0.22)(3.09)(1.22)(3.70)
Weighted Avg Shares74.9M66.25M53.18M45.74M45.13M
Weighted Avg Shares (Diluted)74.9M66.25M53.18M45.9M45.13M

Azenta, Inc.

NASDAQ:AZTA

Intrinsic Alpha fair value

Locked

Current Price

$48.69

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.